C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. by Sivadasan, R. et al.
This is an author produced version of C9ORF72 interaction with cofilin modulates actin 
dynamics in motor neurons..
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/105922/
Article:
Sivadasan, R., Hornburg, D., Drepper, C. et al. (11 more authors) (2016) C9ORF72 
interaction with cofilin modulates actin dynamics in motor neurons. Nature Neuroscience. 
ISSN 1097-6256 
https://doi.org/10.1038/nn.4407
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
C9ORF72 interaction with cofilin modulates actin dynamics 
in motoneurons 
 
Running title: C9ORF72 and actin dynamics  
 
Rajeeve Sivadasan 1, Daniel Hornburg #2, Carsten Drepper# 1, Nicolas Frank 1, 
Sibylle Jablonka1, Anna Hansel1, Xenia Lojewski3; Jared Sterneckert5, Andreas 
Hermann3,5,6, Pamela Shaw4, Paul Ince4, Matthias Mann2, Felix Meissner2, Michael 
Sendtner1*. 
1Institute of Clinical Neurobiology, University Hospital of Wuerzburg, Wuerzburg, 
Germany. 
2Max Planck Institute of Biochemistry, Martinsried, 82152, Germany 
3
 Dept of Neurology, Technische Universität Dresden, 01307 Dresden, Germany 
4
 Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 
Sheffield S10 2HQ, UK 
5 Center for Regenerative Therapies Dresden (CRTD), Technische Universität 
Dresden, 01307 Dresden, Germany 
6 German Center for Neurodegenerative Diseases (DZNE), 01307 Dresden, Germany 
 
*To whom correspondence should be addressed: Sendtner_M@ukw.de, Michael 
Sendtner, Institute of Clinical Neurobiology, University of Wuerzburg, Versbacher Str. 
5, 97078 Wuerzburg, Germany, Tel +49 931 201 44000, Fax +49 931 201 44009. 
# Equal contributors 
 
 
 
 
 
 
Abstract 
Intronic hexanucleotide expansions in C9ORF72 are common in ALS and FTLD, 
but it is unknown whether loss of function, toxicity by the expanded RNA or 
dipeptides from non ATG-initiated translation are responsible for the 
pathophysiology. We determined the interactome of C9ORF72 in motoneurons 
and found that C9ORF72 is present in a complex with cofilin and other actin 
binding proteins. Phosphorylation of cofilin is enhanced in C9ORF72 depleted 
motoneurons, in patient derived lymphoblastoid cells, iPS cell derived 
motoneurons and post-mortem brain samples from ALS patients. C9ORF72 
modulates the activity of the small GTPases Arf6 and Rac1, resulting in 
enhanced activity of LIMK1/2. This results in reduced axonal actin dynamics in 
C9ORF72 depleted motoneurons. Dominant negative Arf6 rescues this defect, 
suggesting that C9ORF72 acts as a modulator of small GTPases in a pathway 
that regulates axonal actin dynamics.  
 
 
 
 
 
  
Introduction 
Amyotrophic lateral sclerosis (ALS) is the most common form of motoneuron 
disease in the adult. Both sporadic and familial forms exist, and with the discovery of 
a GGGGCC (G4C2) intronic repeat expansion in the C9ORF72 gene, a common 
genetic cause of familial ALS has been identified 1, 2. The same intronic repeat 
expansion has also been discovered in patients with frontotemporal dementia (FTLD) 
2
, the second most common form of presenile dementia after Alzheimer´s disease. 
Interestingly, ALS and FTLD often co-occur in families and sometimes present in the 
same patients (FTLD-ALS), with similar clinicopathological features 1-4. In healthy 
individuals, the number of repeats ranges from 2 to 23. In patients with ALS and 
FTLD, sixty to several hundred G4C2 repeats are found in the C9ORF72 gene 4, 5. 
The mechanism by which G4C2 repeat expansions cause neurodegenerative 
disease is still not clear. Three main hypotheses are currently discussed 6. The first 
proposes that G4C2 repeat transcript as well as the antisense repeat transcript may 
accumulate in RNA foci which sequester RNA-binding proteins, leading to disturbed 
RNA metabolism that causes neurodegeneration 7-9. The second hypothesis builds 
on observations that the long repeat gives rise to proteins consisting of dipeptides by 
non-ATG translation (RAN translation) 10. These dipeptide repeat proteins can then 
aggregate and cause neurodegeneration in affected brain regions 11. The third 
hypothesis suggests that the expansion of repeats leads to haploid insufficiency of 
C9ORF72 expression, thereby resulting in loss of function 2. Which of these different 
mechanisms predominates or whether they act together in the pathophysiology of 
ALS and FTLD is currently unknown. In particular, little is known about the effects of 
loss of function of the protein encoded byC9ORF72, because its physiological role is 
still unclear. 
Loss of function is a possible pathomechanism as patients with C9ORF72 repeat 
expansion show a 50% reduction in mRNA levels of both long and short transcripts 2, 
3
. Recent studies revealed that reduction of C9ORF72 levels in both cortical and 
motoneurons does not affect cellular survival in vitro 10 or in vivo 12. However, 
zebrafish models show reduced axon length in motoneurons and reduced locomotion 
after antisense morpholino-mediated reduction of C9ORF72 levels 5. In contrast to 
the results in C. elegans and zebrafish, studies in mouse have so far not revealed 
conclusive results for C9ORF72 loss of function as a possible cause of FTLD/ALS 13-
16
. Administering antisense oligonucleotides (ASOs) targeting mouse C9ORF72 by 
stereotactic intracerebroventricular (ICV) injection reduced C9ORF72 mRNA levels to 
30-40% of control levels in the spinal cord and brain 17. C9ORF72 depletion in these 
mice was well tolerated and did not result in any behavioural or motor impairment. A 
mouse with a conditional knockout allele for C9ORF72 was generated using the 
Cre/loxP system. These mice were crossed to Nestin-Cre mice, which express Cre 
recombinase in neurons and glia starting at E10.5 and continuing into adulthood 18. 
Cre-mediated inactivation of C9ORF72 in neurons and glia did not cause loss in 
motoneuron numbers or in motor function, including motor performance and grip 
strength 19. Hallmarks of ALS pathologies such as ubiquitinated TDP-43 aggregates 
and gliosis were not detected either. Thus, in two different mouse models, loss of 
C9ORF72 function is not sufficient to cause neurodegeneration and FTLD/ALS-
related phenotypes.  
However, these finding do not preclude the possibility that loss of C9ORF72 function 
contributes to neurodegeneration when combined with toxicity of dipeptides 
generated via RAN translation or dysregulated RNA metabolism. Loss of C9ORF72 
in Neuro-2A cells has been shown to disturb the function of a complex involving 
WDR41 and SMCR8 which modulates GTPase function of Rab8a and Rab39b, 
leading to impaired autophagy in neurons 20. To characterize the function of 
C9ORF72 in motoneurons, we investigated the interactome of C9ORF72 with 
quantitative proteomics and found that it immunoprecipitates with cofilin and other 
actin binding proteins. Functional analyses in isolated mouse motoneurons and 
human iPS cells as well as post-mortem analyses of patient brain tissues revealed a 
role of C9ORF72 as a modulator of actin dynamics via a pathway involving 
phosphorylation of cofilin through Arf6, Rac1 and LIMK1/2 activity. The resulting loss 
of actin dynamics could contribute to the capacity of neurons to maintain axons and 
axon terminals in the cellular pathology underlying ALS and FTLD 
 
Results 
C9ORF72 modulates axon growth in cultured motoneurons 
To understand the cellular function of C9ORF72, we used lentiviral vectors (Suppl. 
Fig. 1A,B) to overexpress or knockdown C9ORF72 in primary mouse embryonic 
motoneurons. Immunostaining (Fig. 1A,B), RT-PCR (Suppl. Fig. 1C) and 
immunoblots (Supplementary Fig. 1D) showed that C9ORF72 levels were reduced 
(Suppl. Fig. 1C) or enhanced (Suppl. Fig. 1D,E) by about 50%, respectively, in 
primary mouse motoneurons cultured for 7 days. Overexpression or knockdown of 
the protein did not affect the survival of the cultured motoneurons (Suppl. Fig. 2A). 
Interestingly, compared to controls axons were significantly longer in C9ORF72-
overexpressing motoneurons at 7 days in culture (Fig. 1C,D, Suppl. Fig. 2B), and 
significantly shorter after knockdown . The knockdown effect could be rescued by 
overexpression of human C9ORF72, indicating that is not due to off target effects 
(Suppl. Fig. 2C). C9ORF72 overexpression also led to increased growth cone size at 
day 5 in culture while knockdown reduced growth cone size compared to control (Fig. 
1D). These results indicate that C9ORF72 modulates axonal growth and growth cone 
size in spinal motoneurons. 
 
C9ORF72 interacts with Cofilin 
To investigate the mechanism by which C9ORF72 acts on axon growth and 
differentiation, we determined interacting proteins by mass spectrometry (MS)-based 
proteomics. Due to the lack of suitable antibodies against mouse C9ORF72 protein, 
immunoprecipitation of endogenous protein was not possible. Therefore, we 
overexpressed HA-tagged human C9ORF72 protein and immunoprecipitated 
interacting proteins from NSC-34 cells (Suppl. Fig. 3A,B,C). Interacting proteins were 
then analyzed by quantitative interaction proteomics as described 21, 22. Key 
regulators of actin dynamics such as cofilin, Arp2/3 and coronin were among 
statistically significant interaction partners of C9ORF72 (Fig 2A, Suppl Excel Sheet 
1). For further analysis, we first focussed on cofilin, of which we identified two family 
members (Cfl1 and Clf2) as significant C9ORF72 interactors, because cofilin plays a 
central role in the regulation of actin dynamics and could therefore be responsible for 
reduced axon growth 23 and reduced size of axonal growth cones 24. 
Immunoprecipitation of C9ORF72-HA from primary mouse motoneurons confirmed 
the interaction with cofilin by immunoblot analysis (Fig. 2B, Suppl. Fig. 4A,B). 
Endogenous cofilin pulldown revealed even stronger binding both of overexpressed 
C9ORF72-HA (Fig. 2B) and endogenous C9ORF72 (Fig. 2C, right panel), probably 
because cofilin is more abundant in motoneurons and NSC-34 cells than the 
C9ORF72 protein 25. This interaction was further confirmed by immunostaining in 
cultured mouse motoneurons, showing that C9ORF72-HA
the cell body, axon shaft (Fig. 2D) and in particular in the axonal growth cone (Fig. 
2E, Suppl. Fig.4C,D). 
 
C9ORF72 depletion enhances phosphorylation of cofilin 
Cofilin is a ubiquitous actin-binding factor required for the reorganization of actin 
filaments. It promotes actin assembly or disassembly depending on its concentration 
relative to actin and relative to the concentration of other actin-binding proteins 26. 
The activity of cofilin depends on phosphorylation at Ser3 which inactivates its 
function in F-actin assembly 27. We found that overexpression of C9ORF72-HA 
protein reduced phosphorylation while knockdown increased cofilin phosphorylation 
(Fig. 3A) without any change in total cofilin levels (Fig. 3A,B). To test whether actin 
dynamics is also altered in human cells with C9ORF72 intronic expansion, we 
investigated immortalized lymphoblasts from three age-matched control and three 
C9ORF72 repeat expansion-carrier ALS patients. Immunoblots of lymphoblastoid cell 
extracts from these patients showed an upregulation of cofilin phosphorylation (Fig. 
3C,D). In order to study whether these cell culture experiments are representative of 
patients at disease stage, we investigated post-mortem brain tissue from three ALS 
patients with C9ORF72 intronic expansion and three age related controls. Using 
protein extracts from post-mortem cerebellum, we found reduced levels of 
endogenous C9ORF72 (p=0.0002, unpaired student´s t-test) in the patient samples, 
and a more than 3-fold upregulation of cofilin phosphorylation (p=0.0002, unpaired 
student´s t test) in the absence of altered cofilin levels (Fig. 3E,F). The results from 
cultured mouse motoneurons, patient derived lymphoblastoid cells and post-mortem 
brain tissue together demonstrate that cofilin phosphorylation is enhanced after 
depletion of C9ORF72 and under the genetic conditions of C9ORF72 intronic 
hexanucleotide expansion in patients. 
 
Actin dynamics is disturbed in C9ORF72 depleted or mutated motoneurons  
We next tested whether C9ORF72 has an influence on actin dynamics and cloned 
cytoplasmic actin linked with GFP into a shRNA lentiviral vector for C9ORF72 
repression (Suppl. Fig. 5A). This allowed us to study actin dynamics by live cell 
imaging of cultured mouse motoneurons lacking C9ORF72. A scrambled sequence 
was used for the control GFP-actin construct. The expression of both constructs was 
confirmed by Western blotting and immunostaining (Suppl. Fig. 5B,C), which showed 
colocalization of GFP-actin with phalloidin. We performed live cell imaging with 
mouse motoneurons at 5 days in culture because at this stage axon extension 
appears with highest speed and dynamics 28 (Fig. 4A, Suppl. Movie 1-2). The number 
of newly generated actin filaments was reduced in C9ORF72 depleted motoneurons 
(Fig. 4B). C9ORF72 knockdown led to a significantly reduced velocity of actin 
movement in axonal growth cones compared to motoneurons transduced with 
scrambled control constructs (Fig. 4C,D). The dynamics of growth cone movement, 
as measured by the area into which the growth cone expanded over time was also 
significantly reduced (Fig. 4E). Thus actin dynamics is impaired when C9ORF72 
levels are reduced in motoneurons. We then investigated actin dynamics in iPSC 
derived human motoneurons from C9-ALS patients (Suppl.Fig.6, 7). Consistent with 
our observations in primary mouse motoneurons after C9ORF72 suppression, these 
induced human motoneurons showed reduced velocity of actin movement in axonal 
growth cones compared to control patient derived human motoneurons (Fig. 4 F-I). In 
parallel to the live cell imaging, we performed protein fractionation of F-actin and G-
actin, which confirmed that G/F actin ratios are altered when C9ORF72 is knocked 
down or overexpressed in mouse motoneurons (Fig. 5A-D).  
 
C9ORF72 depletion leads to activation of Arf6  
Cofilin ability to bind and depolymerize actin is abolished by phosphorylation of serine 
residue 3 27, 29. The kinases responsible for this phosphorylation are LIM-kinase 1 
(LIMK-1) and LIMK-2 30. LIMK-1/2 can phosphorylate cofilin at Ser3, both in vitro and 
in vivo 31. Therefore, we tested whether cofilin phosphorylation is regulated by LIMK-
1/2 phosphorylation by analyzing phospho-LIMK-1/2 levels after overexpression or 
knockdown of C9ORF72 in primary mouse motoneurons after 7 days in culture. 
Overexpression of C9ORF72-HA protein reduced LIMK-1/2 phosphorylation while 
knockdown increased LIMK-1/2 phosphorylation (Fig. 6A) without any change in total 
LIMK protein levels. We then analysed cofilin and LIMK phosphorylation in patient 
iPS cells derived motoneurons matured for 14 days (Fig. 6B). Interestingly, a similar 
phenotype was observed as in C9ORF72 depleted mouse motoneurons. These 
results indicate that C9ORF72 influences the phosphorylation of LIMK which directly 
regulates the activity of cofilin.  
Recent publication have shown that C9ORF72 protein has homology to the 
Differentially Expressed in Normal and Neoplasia (DENN) protein family, which 
function as guanine nucleotide exchange factors (GEFs) or modulators of guanine 
nucleotide exchange factors to regulate Rab GTPase activity 32, 33. Therefore, we 
searched for potential small GTPases among the proteins found in the C9ORF72 
interactome and identified ADP-ribosylation factor-1 (Arf1) and Arf6 (Fig. 6C,D). Arfs 
34
 constitute a family of Ras-related, low molecular mass (׽20 kDa) GTP-binding 
proteins that act as molecular switches for membrane and vesicle traffic as well as 
actin dynamics in cells 35. In a first step, the interaction of C9ORF72 with these small 
GTPases was confirmed by co-precipitation analyses, using antibodies against Arf6 
(Fig. 6C). This study was limited by the quality of available antibodies, and therefore 
complemented by experiments in which flag-tagged Arf1 and Arf6 were 
overexpressed in NSC34 cells (Fig. 6D). Pulldown with FLAG antibodies confirmed 
that C9ORF72 co-precipitates with Arf1 and Arf6 and thus might be present in the 
same complexes. Arf6 plays an essential role in membrane trafficking and 
cytoskeletal rearrangement both in neuronal 36 and non-neuronal cells 37. We 
therefore analyzed the activity of Arf6 with gel shift assays to investigate whether 
C9ORF72 acts as a modulator of GTP/GDP binding to Arf6. The results show that 
C9ORF72 depletion in NSC-34 cells elevates the levels of GTP-bound Arf6 (Fig. 7A-
C), indicating that C9ORF72 does not act as a GEF for Arf6, but that it is involved in 
modulating this pathway. Rac1 acts as a downstream mediator of Arf6 activation 38 in 
a pathway that modulates actin dynamics. In order to study this pathway, we 
performed active GTPase immunoprecipitation assays in which the GTP-found forms 
of Arf6 and Rac1 were pulled down. These data indicate that levels of the GTP-
bound forms of these small GTPases are increased in the absence of C9ORF72 (Fig. 
7D-F), thus suggesting a mechanism by which actin dynamics is disturbed. The 
reduced level of C9ORF72 leads to more active form of GTP-bound ARF6 which 
activates Rac1, thus leading to the phosphorylation of LIMK-1/2 and as a 
consequence to inactivation of cofilin by phosphorylation at Ser3. In order to test this 
hypothesis in more detail, we investigated whether knockdown of Arf6 could restore 
cofilin phosphorylation and altered axonal actin dynamics in motoneurons. Therefore 
we investigated Rac1 activation in iPSc cells derived motoneurons from C9-ALS 
patients. Under control conditions, enhanced Rac1 was observed, but knockdown of 
Arf6 by shRNA rescued this phenotype (Fig. 8A,B). As a second line of evidence we 
investigated whether overexpression of constitutively dominant negative Arf6 
(resembling Arf6-GDP) in parallel with knockdown of mouse C9ORF72 could rescue 
the axonal elongation phenotype. The results from (Fig 8C,D) demonstrate that the 
axonal elongation phenotype observed after knockdown of mouse C9ORF72 was 
rescued with overexpression of dominant negative Arf6. 
Together our data provide evidence that C9ORF72 plays a cellular role in regulating 
actin dynamics via regulation of the GTPase activity of Arf6, cofilin phosphorylation 
and possibly other proteins shaping the actin cytoskeleton. Our data also explain the 
axonal phenotype observed in zebrafish after C9ORF72 suppression5. Thus, loss of 
function of C9ORF72 could contribute to the clinical phenotype in ALS and FTLD, 
because reduced actin dynamics influences synaptic strength 39 , maintenance 40 and 
axon stability 40. 
 
 
Discussion  
Several previous studies have shown that cells derived from C9ORF72 patients have 
decreased levels of C9ORF72 transcripts 5, raising the on the cellular function of 
C9ORF72 and whether loss of this function could contribute to the pathophysiology 
of ALS and FTLD 6. C9ORF72 has been implicated in intra-cellular membrane 
trafficking 32, 33. Our Mass spectrometry (LC-MS), immunoprecipitation analyses 
releaved that C9ORF72 is in a complex with key regulators of actin dynamics such as 
Cofilin, Arp2/3 and Coronin. Cofilin is an ubiquitous actin-binding factor required for 
the organization of actin filaments 26. The activity of cofilin depends on 
phosphorylation at Ser3 which inactivates its function in F-actin assembly 27, 29. 
Recent studies have shown that cofilin plays an essential role for actin bundling in 
axons, and that augmented retrograde flow of actin filaments appears as an essential 
component of axon elongation 23. The same study showed that cofilin knockout 
results in impaired axon growth, similar as in C9ORF72 depleted mouse 
motoneurons observed in our study. This emphasizes the importance of cofilin 
activity for axonal maintenance in motoneurons. The activity of cofilin is regulated by 
phosphorylation through LIMK-1/2. These serine threonine kinases are activated by 
effector kinases of small GTPases, in particular PAK1 and PAK4 42 These effector 
kinases act downstream of Rac1 which itself is activated by Arf6 38, 43 and Arf1 44. 
The observation that the GTP bound form of Rac1 and Arf6 are relatively increased 
when C9ORF72 is repressed in primary mouse motoneurons, or in iPS cell derived 
motoneurons strongly suggest that C9ORF72 plays an essential role for the GTP 
exchange activity in particular of Arf6. This conclusion is supported by the 
observation that knockdown of Arf6 expression of iPS cell derived motoneurons 
normalizes the enhanced levels of GTP bound Rac1. Expression of a dominant 
negative Arf6 36 or depletion of Arf6 45 enhances axon elongation which fully supports 
our observation that enhanced activity of Arf6 in C9ORF72 deficient neurons 
correlates with reduced axon growth, and that expression of a dominant negative 
Arf6 in C9ORF72 depleted motoneurons or in iPS cell derived motoneurons from C9-
ALS patients rescues the axonal defects observed after C9ORF72 depletion. 
Bioinformatic analysis has revealed that C9ORF72 contains a DENN domain that is 
characteristic of the family of DENN proteins, some of which showing activity as 
GDP/GTP exchange factors for Rab GTPases and possibly also other small 
GTPases 32, 33. This appeared in line with the observation that C9ORF72 colocalized 
with Rab1, Rab5, Rab7 and Rab11 and that depletion of C9ORF72 inhibited 
endocytosis and vesicle trafficking in neuronal cell lines 46. A recent study identified 
C9ORF72 protein in Neuro-2A cells as component of a complex with SMCR8 and 
WDR3 exhibiting GEF activity for Rab8a and Rab39 20. In our mass spectrometric 
analysis, we did not observe a specific interaction of C9ORF72 with SMCR8 and 
WDR41. This is possibly due to the fact that the proteomes of Neuro-2A cells and 
primary motoneurons differ significantly 25, in particular with respect to proteins 
relevant for cytoskeletal organization and pre-synaptic differentiation. This previous 
study also did not find evidence that the C9ORF72 protein itself acts as a GEF for 
these Rab proteins. SMCR8 bound to Rab8 and Rab39 independently of C9ORF72, 
indicating that C9ORF72 itself does not function as a GEF in this context but rather 
as a modulator of the GEF activity of SMCR8. Thus, the question remains open 
whether small GTPases are modulated directly by C9ORF72, and how C9ORF72 
achieves this function as a modulator of GDP/GTP binding 32, 33. In our study, we 
identified enhanced GTP binding in Arf6 and Rac1 after C9ORF72 depletion. This 
effect was also observed in iPS cell derived motoneurons from C9-ALS patients, in 
lymphoblastoid cells and in the postmortem brain samples from C9-ALS patients. We 
do not know yet how C9ORF72 modulates the GTP binding of these small GTPases. 
This could be via action as a GEF for one or more upstream small GTPases, or via 
inhibition of other GEFs for Arf6 and Rac1 which then results in LIMK-1/2 and 
phosphorylation of cofilin. Such potential allosteric mechanisms that modulate GEF 
activity have been identified in the context of differential regulation of Ras and Rac 
activity by Sos. When Sos is bound to Abi1/E3B1, Eps8 and PI3K 47, it acts as a GEF 
for Rac. However, when Sos is bound to Abi1/E3b1, it cannot bind to Grb3, and thus 
its GEF activity for Ras is reduced 48. Such a mechanism could explain the enhanced 
GTP binding of Arf6 and Rac1 when C9ORF72 levels are low in iPS cell derived 
motoneurons, in postmortem brain samples for C9-ALS patients and in primary 
mouse motoneurons after lentiviral C9ORF72 knockdown.  
The presence of Cofilin, Coronin and other actin modulatory proteins in complexes 
with endogenous C9ORF72 indicates that the modulation of actin dynamics could 
constitute an essential cellular function C9ORF72 in motoneurons. Enhanced 
phosphorylation of LIMK-1/2 and cofilin in iPSC derived neurons and in postmortem 
brain samples of C9-ALS patients indicates that this mechanism might contribute to 
the pathology in ALS and FTLD.  
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